Treating cancer symptoms improves quality of life. Part 1: Treatment of anaemia and fatigue

International Journal of Pharmaceutical Medicine

Volumn 14, Issue 2, 2000, Pages 88-91

  Sabbatini, Paul ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Anaemia; Cancer; Epoetin alfa; Haemoglobin levels; Quality of life

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CANCER; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOM;

EID: 0034119078     PISSN: 13649027     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124363-200004000-00010     Document Type: Conference Paper

References (16)

1. 1. Curt GA, Breitbari W, Cella DF, Groopman JE, Horning SJ, Itri L, et al. Impact of cancer-related fatigue on the lives of patients. J Clin Oncol 1999; 18:573a.
2. 2. Coiffier B. Retrospective analysis of hematological parameters and transfusion requirements in non-platinum chemotherapy-treated patients. J Clin Oncol 1998; 17:90A.
3. 3. Dalton JD, Bailey NP, Barrett-Lee PJ, O'Brien MER. Multicenter UK Audit of Anaemia in Patients Receiving Cytotoxic Chemotherapy. J Clin Oncol 1998; 17:418a.
4. 4. Groopman JE, Itri LM. Chemotherapy-induced anaemia in adults: incidence and treatment. J Natl Cancer Inst 1999; 91:1616-34.
5. 5. Cleeland CS, Demetri GD, Glaspy J, Cella DF, Portenoy RK, Cremieux P-Y, et al. Identifying haemoglobin level for optimal quality of life: results of an incremental analysis. J Clin Oncol 1999; 18:547a.
6. 6. Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumour type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 1998; 16:3412-25.
7. 7. Ludwig H, Fritz E. Anaemia in cancer patients. Semin Oncol 1998; 25(3 Suppl 7):2-6.
8. 8. Abels RI, Larholt KM, Krantz KD, Bryant EC. Recombinant human erythropoietin (r-HuEPO) for the treatment of the anaemia of cancer. Proceedings of the Beijing Symposium. In: Murphy MJ, editor. Blood Cell Growth Factors: Their Present and Future Use in Hematology and Oncology. Dayton: AlphaMed Press; 1991. pp. 121-141.
9. 9. Abels RI. Use of recombinant human erythropoietin in the treatment of anaemia in patients who have cancer. Semin Oncol 1992; 19(3 Suppl 8):29-35.
10. 10. Case DC, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 1993; 85:801-806.
11. 11. Henry DH, Abels RI. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anaemia: results of double-blind and open-label follow-up studies. Semin Oncol 1994; 21(2 Suppl 3):21-8.
12. 12. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with non-myeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 1997; 15:1218-34.
13. 13. Gabrilove JL, Einhorn LH, Livingston RB, Winer E, Cleeland CS. Once-weekly dosing of epoetin alfa is similar to three-times-weekly dosing in increasing haemoglobin and quality of life. J Clin Oncol 1999; 18:574a.
14. 14. Gough IR, Furnival CM, Schilder L, Grove W. Assessment of the quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol 1983; 19:1161-5.
15. 15. Maxwell C. Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment. Br J Clin Pharmacol 1978; 6(1):15-24.
16. 16. Huskisson EC. Measurement of pain. Lancet 1974; ii:1127-31.